Filing Details
- Accession Number:
- 0001181431-11-047818
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-09-02 10:50:05
- Reporting Period:
- 2011-08-31
- Filing Date:
- 2011-09-02
- Accepted Time:
- 2011-09-02 10:50:05
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
820096 | Perrigo Co | PRGO | Pharmaceutical Preparations (2834) | 382799573 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1219837 | T David Gibbons | C/O Perrigo Company 515 Eastern Avenue Allegan MI 49010 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2011-08-31 | 12,000 | $95.31 | 30,002 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2011-08-31 | 17,500 | $18.18 | 47,502 | No | 4 | M | Direct | |
Common Stock | Disposition | 2011-08-31 | 17,500 | $95.49 | 3,002 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Employee Stock Option RIght to Buy | Disposition | 2011-08-31 | 17,500 | $0.00 | 35,000 | $18.18 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
17,500 | 2007-03-31 | 2014-03-31 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 13 | Indirect | By Profit Sharing |
Footnotes
- The price in column 4 is a weighted average. The prices actually received ranged from $95.23 to $95.50. For all transactions reported in this Form 4 utilizing a weighted average price, the reporting person undertakes to provide upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range.
- The price in column 4 is a weighted average. The prices actually received ranged from $95.41 to $95.69. For all transactions reported in this Form 4 utilizing a weighted average price, the reporting person undertakes to provide upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range.